Accessibility Menu
 
Braxia Scientific logo

Braxia Scientific

(OTC) BRAXF

Current Price$0.00
Market Cap$300
Since IPO (2020)-100%
5 Year-100%
1 Year-100%
1 Month+0%

Braxia Scientific Financials at a Glance

Market Cap

$300

Revenue (TTM)

$2.21M

Net Income (TTM)

$9.64M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-63.80 (Low)

Price

$0.00

Volume

800

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

BRAXF News

No articles available.

BRAXF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Braxia Scientific

Industry

Healthcare Providers and Services

CEO

Roger S. McIntyre, MD

Headquarters

Mississauga, ON L5G 3H4, CA

BRAXF Financials

Key Financial Metrics (TTM)

Gross Margin

9%

Operating Margin

-4%

Net Income Margin

-7%

Return on Equity

0%

Return on Capital

-4%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$300.00

Shares Outstanding

283.28M

Volume

800

Short Interest

0.00%

Avg. Volume

19.86K

Financials (TTM)

Gross Profit

$171.74K

Operating Income

$7.48M

EBITDA

$12.70M

Operating Cash Flow

$7.40M

Capital Expenditure

$902.59K

Free Cash Flow

$8.30M

Cash & ST Invst.

$1.46M

Total Debt

$207.16K

Braxia Scientific Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$492.44K

+0.7%

Gross Profit

$81.98K

+108.7%

Gross Margin

16.65%

N/A

Market Cap

$300.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$907.05K

+58.2%

EBITDA

$807.51K

+63.8%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$508.29K

-138.1%

Accounts Receivable

$91.03K

-58.0%

Inventory

$0.00

-100.0%

Long Term Debt

$501.04K

+270.5%

Short Term Debt

$135.60K

+74.5%

Return on Assets

-3.38%

N/A

Return on Invested Capital

-4.31%

N/A

Free Cash Flow

$541.67K

+85.1%

Operating Cash Flow

$532.56K

+85.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PBLAPanbela Therapeutics, Inc.
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%
AVXTAVAX Technologies, Inc.
$0.00+0.00%
EHOSEhouse Global, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About BRAXF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.